PosiFunda · Fundamentals

PharmaCorp Rx Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

PharmaCorp Rx Inc. made a loss over the last year.

Compared with Healthcare companies in Canada.

P/E ratio

Loss

PharmaCorp Rx Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.57

The share price is 1.57 times PharmaCorp Rx Inc.'s book value per share, lower than 70% of Healthcare companies in Canada.

Market cap

C$83 M

The total market value of all of PharmaCorp Rx Inc.'s shares at today's price (share price × number of shares), larger than 69% of Healthcare companies in Canada. PosiCap size class: Micro Cap.

Return on equity (ROE)

-2.5%

PharmaCorp Rx Inc. lost 2.5% of its shareholders' money over the last year, higher than 68% of Healthcare companies in Canada.

Dividend yield

None

PharmaCorp Rx Inc. does not currently pay a dividend.

Questions

What is PharmaCorp Rx Inc.'s return on equity?

PharmaCorp Rx Inc. lost 2.5% of its shareholders' money over the last year, higher than 68% of Healthcare companies in Canada.

Does PharmaCorp Rx Inc. pay a dividend?

No. PharmaCorp Rx Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.